文献速递妇科产科

卵巢癌HIPEC中预防顺铂相关急性肾损伤的替代方案评估

Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2026-04-06

本研究纳入180例晚期卵巢癌行间歇性肿瘤减灭术联合腹腔热灌注化疗(HIPEC)的患者,比较硫代硫酸钠方案与水化(含镁钾、乙酰半胱氨酸和甘露醇)方案对术后急性肾损伤(AKI)的影响。结果显示两组AKI发生率无显著差异,估计出血量可能与AKI发生相关(p=0.046),水化方案可作为可行的替代预防方案。

要点

  • 水化联合镁钾、乙酰半胱氨酸和甘露醇方案与硫代硫酸钠方案的AKI发生率相似。
  • 估计出血量是术后AKI发生的潜在相关因素(p=0.046)。
  • 两组无进展生存期相似(p=0.060),替代方案未影响肿瘤结局。

核心结论

  • 水化联合镁钾、乙酰半胱氨酸和甘露醇的预防方案与硫代硫酸钠方案相比,AKI发生率相似,可作为可行的替代方案。

研究设计与样本

  • 回顾性研究,纳入2018年4月至2025年4月期间行间歇性肿瘤减灭术联合HIPEC的晚期卵巢癌患者180例,分为硫代硫酸钠组(90例)和水化组(90例)。
  • AKI依据KDIGO标准、基于术后血清肌酐水平定义。

主要发现

  • 硫代硫酸钠组14例发生I期AKI;水化组9例发生AKI,其中I期6例、II期2例、III期1例。
  • 两组AKI发生率无显著差异。
  • 单因素和多因素分析显示估计出血量与AKI发生相关(p=0.046)。
  • 两组无进展生存期相似(p=0.060)。

关键数值与推荐

  • 硫代硫酸钠组:术前和术后接受硫代硫酸钠(Ametox®)。
  • 水化组:术中接受含镁和钾的液体水化,并围手术期使用乙酰半胱氨酸和甘露醇。
  • AKI定义采用KDIGO标准,基于术后血清肌酐水平。

临床怎么用

  • 对于接受顺铂HIPEC的晚期卵巢癌患者,可考虑采用含镁钾水化联合乙酰半胱氨酸和甘露醇的方案替代硫代硫酸钠预防AKI。
  • 围手术期应关注估计出血量,其与术后AKI发生相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) is an effective treatment to eliminate residual micrometastases and reduce recurrence after interval cytoreductive surgery for ovarian cancer. However, cisplatin is often associated with significant adverse effects, particularly acute kidney injury (AKI). This study aimed to identify factors associated with postoperative AKI and develop an alternative preventive protocol. METHODS: Patients with advanced ovarian cancer who underwent interval debulking surgery with HIPEC between April 2018 and April 2025 were included. Patients were categorized into two groups: sodium thiosulfate and hydration. AKI was defined according to KDIGO criteria, based on postoperative serum creatinine levels. RESULTS: In total, 180 patients were included in the study. Of these, 90 patients received sodium thiosulfate (Ametox®) before and after surgery, whereas 90 were administered intraoperative fluid hydration containing magnesium and potassium, along with acetylcysteine and mannitol during and after surgery. In the Ametox group, 14 patients developed stage I AKI. In the hydration group, nine patients developed AKI, including six with stage I, two with stage II, and one with stage III. The incidence of AKI did not differ significantly between the two groups. Univariate and multivariate analyses identified estimated blood loss as a potential contributor to AKI occurrence (p = 0.046). Progression-free survival was similar between the two groups (p = 0.060). CONCLUSIONS: The protocol utilizing fluid hydration with magnesium and potassium, combined with acetylcysteine and mannitol, was associated with a similar incidence of AKI compared with that in the case of sodium thiosulfate use, suggesting that it may be a feasible alternative.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lee J, Seo K, Kim J, et al. Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer. Gynecol Oncol. 2026. PMID: 41946312. doi:10.1016/j.ygyno.2026.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。